In the BioHarmony Drug Report Database
Carboplatin
Paraplatin (carboplatin) is a small molecule pharmaceutical. Carboplatin was first approved as Paraplatin on 1989-03-03. It is used to treat bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, and esophageal neoplasms amongst others in the USA.
Trade Name
|
Paraplatin |
|---|---|
Common Name
|
carboplatin |
ChEMBL ID
|
CHEMBL1351 |
Indication
|
bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, esophageal neoplasms, germ cell and embryonal neoplasms, lung neoplasms, osteosarcoma, ovarian neoplasms, urinary bladder neoplasms |
Drug Class
|
Antineoplastics (platinum derivatives) |
Image (chem structure or protein)